WCLC展商名录/电子会刊
WCLC会刊咨询
购买须知：
1. 展商名录/电子会刊将在 1-2个工作日 内以 电子邮件形式 发送至 申请人邮箱 ，请注意查收(如未收到请查看垃圾邮箱或
联系 0571-88560061)
2. 在线展商名录/电子会刊仅支持浏览， 不发邮件 ， 不支持复制 文字等内容
3. 购买页面有标注"含电话、邮箱"的为含联系方式的名录，未标即不含联系方式
展会基本信息
展商行业
Core Treatment Areas
Non-Small Cell Lung Cancer (NSCLC): Covers first-line treatment for squamous/non-squamous NSCLC, exploring the application of immune combination therapy in brain metastasis and perioperative patients
Small Cell Lung Cancer (SCLC): Releases progress in the treatment of extensive-stage SCLC, including immunotherapy combined with targeted therapy regimens
Breakthroughs in Innovative Therapies
Immunotherapy: Clinical data updates for PD-1/L1 inhibitors (such as Hanshuang® and HLX43), dual antibody therapies (such as Yivowei)
Targeted Therapy: Latest research progress on EGFR mutations (such as Edotinib) and ALK variations (such as Cadinilimab)
Research on Special Populations
Brain Metastasis Patients: Comparative efficacy of targeted drugs in brain metastatic NSCLC (such as Edotinib vs Osimertinib)
Perioperative Management: Potential applications of immunotherapy before and after lung cancer surgery
Academic Exchange Sessions
The conference features multiple modules, including:
Early Lung Cancer Screening: New technologies such as low-dose CT screening
Advanced Treatment: Clinical progress of ADC drugs, dual antibody therapies
Special Populations: Treatment plans for细分群体specific subgroups such as pediatric and elderly patients
